REMEMBER: Reducing Early Mortality & Morbidity by Empiric Tuberculosis (TB) Treatment
Condition(s):HIV InfectionLast Updated:January 29, 2021Completed
Hide Studies Not Open or Pending
Condition(s):HIV InfectionLast Updated:January 29, 2021Completed
Condition(s):Atypical; Mycobacterium, Pulmonary, TuberculousLast Updated:July 20, 2020Completed
Condition(s):Pulmonary TBLast Updated:January 5, 2024Active, not recruiting
Condition(s):Mycobacterium Avium ComplexLast Updated:May 23, 2017Completed
Condition(s):Tuberculosis, Pulmonary; HIVLast Updated:January 29, 2024Recruiting
Condition(s):TuberculosisLast Updated:March 1, 2017Unknown status
Condition(s):Tuberculosis, PulmonaryLast Updated:September 20, 2017Completed
Condition(s):Tuberculous UveitisLast Updated:February 23, 2024Enrolling by invitation
Condition(s):Tuberculosis, Pulmonary, Drug Sensitive; Tuberculosis, Pulmonary, Multi Drug-resistantLast Updated:March 26, 2019Completed
Condition(s):Tuberculosis, MeningealLast Updated:October 28, 2021Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.